Primeris

Primeris is a biotechnology company that specializes in the development and commercialization of molecular diagnostic tests for infectious diseases. The company was founded in 2011 and is headquartered in Himachal Pradesh, India.

Primeris' product pipeline includes several molecular diagnostic tests for infectious diseases such as tuberculosis, influenza, and diphtheria. The company's tests are designed to provide rapid and accurate diagnosis, which enables healthcare professionals to make timely treatment decisions. Primeris' tests are also designed to aid in the monitoring of disease outbreaks and the tracking of antibiotic resistance.

The company's flagship product is the TB Strip, a rapid molecular diagnostic test for tuberculosis. The TB Strip is a lateral flow strip test that detects the presence of Mycobacterium tuberculosis in sputum samples. The test provides results in under 30 minutes, allowing for rapid treatment initiation.

Primeris has partnered with several international organizations, including the World Health Organization (WHO) and the Global Fund, to develop and distribute its tests in low- and middle-income countries. The company has also received funding from several investors, including the Bill and Melinda Gates Foundation.

Primeris is committed to providing access to high-quality diagnostic tools to healthcare professionals in resource-limited settings. The company's products have the potential to improve patient outcomes and aid in the global efforts to eliminate infectious diseases.